Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 1/2021

09.11.2020 | Letter to the Editor

Peripheral blood T lymphocytosis in thymoma: an insight into immunobiology

verfasst von: Shruti Mishra, Somanath Padhi, Amit Kumar Adhya, Saroj Kumar DasMajumdar, Ashutosh Pattnaik, Gaurav Chhabra

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Peripheral blood T lymphocytosis (PBTL) is a rare, yet poorly understood manifestations of thymoma, which is postulated to be linked with autoimmune/paraneoplastic manifestations such as myasthenia gravis (MG), pure red cell aplasia (PRCA), etc.; more commonly encountered in this neoplasm.

Method

We aim to describe the flowcytometric immunophenotypic data of PBTL in a 43-year-old male; 6 months after successful completion of chemoradiotherapy (CT/RT) for a large, invasive, and metastatic type B1 thymoma; and present a comprehensive review of all such cases reported over last 42 years (N = 21) (1977–2019).

Result

A larger size of the tumors (≥ 10 cm), presence of local invasion and/or distant metastasis, and type B (cortical or lymphocyte rich) histology were more likely to be associated with PBTL. Tumors associated with MG/PRCA (N = 9/21) tend to have lower PBTL compared to those without such manifestations; and PBTL subsided following thymectomy with or without CT/RT. Immunophenotypic analysis of PB revealed a CD8 +  > CD4 + mature (naïve) polyclonal T cells resembling late cortical thymocytes.

Conclusion

Thymic intratumoral microenvironment might influence occurrence PBTL that may have a pathophysiologic link to development of autoimmune manifestations. Immunophenotypic characteristics of peripheral blood lymphoid cells should be the clue for accurate characterization and to avoid a misdiagnosis of a lymphoproliferative neoplasm.
Literatur
Zurück zum Zitat Barton AD (1997) T-cell lymphocytosis associated with lymphocyte-rich thymoma. Cancer 80:1409–1417CrossRef Barton AD (1997) T-cell lymphocytosis associated with lymphocyte-rich thymoma. Cancer 80:1409–1417CrossRef
Zurück zum Zitat Bauduer F, Archambaud F, Mazères F, Ellie E, Ducout L (2002) T-cell lymphocytosis associated with thymoma and myasthenia. Rev Med Interne 23:951–952CrossRef Bauduer F, Archambaud F, Mazères F, Ellie E, Ducout L (2002) T-cell lymphocytosis associated with thymoma and myasthenia. Rev Med Interne 23:951–952CrossRef
Zurück zum Zitat Buckley C, Douek D, Newsom-Davis J, Vincent A, Willcox N (2001) Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis. Ann Neurol 50:64–72CrossRef Buckley C, Douek D, Newsom-Davis J, Vincent A, Willcox N (2001) Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis. Ann Neurol 50:64–72CrossRef
Zurück zum Zitat Chen HK, Huang WT, Eng HL, Lu HI, Huang HY (2009) Ossifying thymoma clinically presenting with peripheral T-cell lymphocytosis. Ann Thorac Surg 88:e5-7CrossRef Chen HK, Huang WT, Eng HL, Lu HI, Huang HY (2009) Ossifying thymoma clinically presenting with peripheral T-cell lymphocytosis. Ann Thorac Surg 88:e5-7CrossRef
Zurück zum Zitat Cranney A, Markman S, Lach B, Karsh J (1997) Polymyositis in a patient with thymoma and T cell lymphocytosis. J Rheumatol 24:1413–1416PubMed Cranney A, Markman S, Lach B, Karsh J (1997) Polymyositis in a patient with thymoma and T cell lymphocytosis. J Rheumatol 24:1413–1416PubMed
Zurück zum Zitat Doll DC, Landreneau RJ, List AF (1991) Malignant thymoma associated with peripheral T-cell lymphocytosis. Med Pediatr Oncol 19:496–498CrossRef Doll DC, Landreneau RJ, List AF (1991) Malignant thymoma associated with peripheral T-cell lymphocytosis. Med Pediatr Oncol 19:496–498CrossRef
Zurück zum Zitat de Jong D, Richel DJ, Schenkeveld C, Boerrigter L, Van’t Veer L (1997) Oligoclonal peripheral T-cell lymphocytosis as a result of aberrant T-cell development in a cortical thymoma. Diagn Mol Pathol 6:244–248CrossRef de Jong D, Richel DJ, Schenkeveld C, Boerrigter L, Van’t Veer L (1997) Oligoclonal peripheral T-cell lymphocytosis as a result of aberrant T-cell development in a cortical thymoma. Diagn Mol Pathol 6:244–248CrossRef
Zurück zum Zitat Griffin JD, Aisenberg AC, Long JC (1978) Lymphocytic thymoma associated with T-cell lymphocytosis. Am J Med 64:1075–1079CrossRef Griffin JD, Aisenberg AC, Long JC (1978) Lymphocytic thymoma associated with T-cell lymphocytosis. Am J Med 64:1075–1079CrossRef
Zurück zum Zitat Hoffacker V, Schultz A, Tiesinga JJ, Gold R, Schalke B, Nix W et al (2000) Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease. Blood 96:3872–3879CrossRef Hoffacker V, Schultz A, Tiesinga JJ, Gold R, Schalke B, Nix W et al (2000) Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease. Blood 96:3872–3879CrossRef
Zurück zum Zitat Huh HJ, Chung JW, Lee HJ, Chae SL (2015) Unusual association of CD8+ T-cell lymphocytosis with invasive thymoma. Blood Res 50:179–185CrossRef Huh HJ, Chung JW, Lee HJ, Chae SL (2015) Unusual association of CD8+ T-cell lymphocytosis with invasive thymoma. Blood Res 50:179–185CrossRef
Zurück zum Zitat Handa SI, Schofield KP, Sivakumaran M, Short M, Pumphrey RS (1994) Pure red cell aplasia associated with malignant thymoma, myasthenia gravis, polyclonal large granular lymphocytosis and clonal thymic T cell expansion. J Clin Pathol 47:676–679CrossRef Handa SI, Schofield KP, Sivakumaran M, Short M, Pumphrey RS (1994) Pure red cell aplasia associated with malignant thymoma, myasthenia gravis, polyclonal large granular lymphocytosis and clonal thymic T cell expansion. J Clin Pathol 47:676–679CrossRef
Zurück zum Zitat Medeiros LJ, Bhagat SK, Naylor P, Fowler D, Jaffe ES, Stetler-Stevenson M (1993) Malignant thymoma associated with T-cell lymphocytosis. A case report with immunophenotypic and gene rearrangement analysis. Arch Pathol Lab Med 117:279–283PubMed Medeiros LJ, Bhagat SK, Naylor P, Fowler D, Jaffe ES, Stetler-Stevenson M (1993) Malignant thymoma associated with T-cell lymphocytosis. A case report with immunophenotypic and gene rearrangement analysis. Arch Pathol Lab Med 117:279–283PubMed
Zurück zum Zitat Morales M, Trujillo M, Maeso MC, Piris MA (2007) Thymoma and progressive T-cell lymphocytosis. Ann Oncol 18:603–604CrossRef Morales M, Trujillo M, Maeso MC, Piris MA (2007) Thymoma and progressive T-cell lymphocytosis. Ann Oncol 18:603–604CrossRef
Zurück zum Zitat Otton SH, Standen GR, Ormerod IE (2000) T-cell lymphocytosis associated with polymyositis, myasthenia gravis and thymoma. Clin Lab Haematol 22:307–308CrossRef Otton SH, Standen GR, Ormerod IE (2000) T-cell lymphocytosis associated with polymyositis, myasthenia gravis and thymoma. Clin Lab Haematol 22:307–308CrossRef
Zurück zum Zitat Puljiz Z, Karin Z, Bratanic A, Kresak VG, Pulzij M, Forempoher G et al (2013) Late distant metastases of malignant thymoma associated with peripheral T-cell lymphocytosis. Pathol Int 63:516–518CrossRef Puljiz Z, Karin Z, Bratanic A, Kresak VG, Pulzij M, Forempoher G et al (2013) Late distant metastases of malignant thymoma associated with peripheral T-cell lymphocytosis. Pathol Int 63:516–518CrossRef
Zurück zum Zitat Pedraza MA (1977) Thymoma, immunological and ultrastructural classification. Cancer 39:1455–1461CrossRef Pedraza MA (1977) Thymoma, immunological and ultrastructural classification. Cancer 39:1455–1461CrossRef
Zurück zum Zitat Shachor Y, Radnay J, Bernheim J, Rozenszajn A, Bruderman I, Klajman A, Steiner ZP (1988) Malignant thymoma with peripheral blood lymphocytosis. Cancer 61:1222–1227CrossRef Shachor Y, Radnay J, Bernheim J, Rozenszajn A, Bruderman I, Klajman A, Steiner ZP (1988) Malignant thymoma with peripheral blood lymphocytosis. Cancer 61:1222–1227CrossRef
Zurück zum Zitat Smith GP, Perkins SL, Segal GH, Kjeldsberg CR (1994) T-cell lymphocytosis associated with invasive thymomas. Am J Clin Pathol 102:447–453CrossRef Smith GP, Perkins SL, Segal GH, Kjeldsberg CR (1994) T-cell lymphocytosis associated with invasive thymomas. Am J Clin Pathol 102:447–453CrossRef
Zurück zum Zitat Soler J, Estivill X, Ayats R, Brunet S, Pujol-Moix N (1985) Chronic T-cell lymphocytosis associated with pure red cell aplasia, thymoma, and hypogammaglobulinemia. Br J Haematol 61:582–584CrossRef Soler J, Estivill X, Ayats R, Brunet S, Pujol-Moix N (1985) Chronic T-cell lymphocytosis associated with pure red cell aplasia, thymoma, and hypogammaglobulinemia. Br J Haematol 61:582–584CrossRef
Zurück zum Zitat Ströbel P, Helmreich M, Menioudakis G, Lewin SR, Rüdiger T, Bauer A et al (2002) Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4+ T cells in thymomas. Blood 100:159–166CrossRef Ströbel P, Helmreich M, Menioudakis G, Lewin SR, Rüdiger T, Bauer A et al (2002) Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4+ T cells in thymomas. Blood 100:159–166CrossRef
Zurück zum Zitat Tabata R, Tabata C, Yamamoto N, Shibuya S, Yasumizu R, Kojima M (2018) Progressive peripheral CD8+ T lymphocytosis complicated by pure red cell aplasia following immunosuppressive therapy for thymoma-associated myasthenia gravis. Int Immunopharmacol 63:14–18CrossRef Tabata R, Tabata C, Yamamoto N, Shibuya S, Yasumizu R, Kojima M (2018) Progressive peripheral CD8+ T lymphocytosis complicated by pure red cell aplasia following immunosuppressive therapy for thymoma-associated myasthenia gravis. Int Immunopharmacol 63:14–18CrossRef
Zurück zum Zitat Tamaoki J, Chiyotani A, Nagai A, Konno K (1997) Invasive thymoma with CD4+CD8+double–positive T cell lymphocytosis. Respiration 64:176–178CrossRef Tamaoki J, Chiyotani A, Nagai A, Konno K (1997) Invasive thymoma with CD4+CD8+double–positive T cell lymphocytosis. Respiration 64:176–178CrossRef
Zurück zum Zitat Yokoi K, Miyazawa N, Kano Y, Akutsu M, Mori K, Tominaga K, Imura G (1997) Tumor lysis syndrome in invasive thymoma with peripheral blood T-cell lymphocytosis. Am J Clin Oncol 20:86–89CrossRef Yokoi K, Miyazawa N, Kano Y, Akutsu M, Mori K, Tominaga K, Imura G (1997) Tumor lysis syndrome in invasive thymoma with peripheral blood T-cell lymphocytosis. Am J Clin Oncol 20:86–89CrossRef
Zurück zum Zitat Zhao L, Zhou X, Li Z, Liu Y (2016) Bone metastasis of malignant thymomas associated with peripheral T-cell lymphocytosis. BMC Surg 16:58CrossRef Zhao L, Zhou X, Li Z, Liu Y (2016) Bone metastasis of malignant thymomas associated with peripheral T-cell lymphocytosis. BMC Surg 16:58CrossRef
Metadaten
Titel
Peripheral blood T lymphocytosis in thymoma: an insight into immunobiology
verfasst von
Shruti Mishra
Somanath Padhi
Amit Kumar Adhya
Saroj Kumar DasMajumdar
Ashutosh Pattnaik
Gaurav Chhabra
Publikationsdatum
09.11.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 1/2021
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-020-03440-2

Weitere Artikel der Ausgabe 1/2021

Journal of Cancer Research and Clinical Oncology 1/2021 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.